David Einhorn - Greenlight Capital
Holding/activity history for Gain Therapeutics Inc. (GANX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 588,410 | 0.09 | $3.26 | ||
| 2023 Q3 | 588,410 | 0.11 | Add 7.66% | 0.01 | $3.28 |
| 2023 Q2 | 546,560 | 0.11 | $4.48 | ||
| 2023 Q1 | 546,560 | 0.14 | $4.82 | ||
| 2022 Q4 | 546,560 | 0.12 | $3.13 | ||
| 2022 Q3 | 546,560 | 0.13 | $3.26 | ||
| 2022 Q2 | 546,560 | 0.15 | $3.60 | ||
| 2022 Q1 | 546,560 | 0.14 | $4.09 | ||
| 2021 Q4 | 546,560 | 0.18 | $5.43 | ||
| 2021 Q3 | 546,560 | 0.27 | $7.44 | ||
| 2021 Q2 | 546,560 | 0.34 | $10.00 | ||
| 2021 Q1 | 546,560 | 0.57 | Buy | 0.57 | $14.92 |